159
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Retrospective Comparison of Endoscopic Versus Open Procedure for Mitral Valve Disease

ORCID Icon, , , , &

References

  • Yanagisawa J, Maekawa A, Sawaki S, et al. Three-port totally endoscopic repair vs conventional median sternotomy for atrial septal defect. Surg Today. 2019;49(2):118–123. doi:10.1007/s00595-018-1713-0.
  • Marin Cuartas M, Javadikasgari H, Pfannmueller B, et al. Mitral valve repair: Robotic and other minimally invasive approaches. Prog Cardiovasc Dis. 2017;60(3):394–404. doi:10.1016/j.pcad.2017.11.002.
  • Hawkins RB, Mehaffey JH, Mullen MG, et al. A propensity matched analysis of robotic, minimally invasive, and conventional mitral valve surgery. Heart. 2018;104(23):1970–1975. doi:10.1136/heartjnl-2018-313129.
  • Bouhout I, Morgant MC, Bouchard D, Minimally invasive heart valve surgery. Can J Cardiol. 2017;33(9):1129–1137. doi:10.1016/j.cjca.2017.05.014.
  • Jiang Q, Yu T, Huang K, et al. Feasibility, safety, and short-term outcome of totally thoracoscopic mitral valve procedure. J Cardiothorac Surg. 2018;13(1):133. doi:10.1186/s13019-018-0819-1.
  • Jiang Q, Xiang B, Wang H, et al. Remote ischaemic preconditioning ameliorates sinus rhythm restoration rate through Cox maze radiofrequency procedure associated with inflammation reaction reduction. Basic Res Cardiol. 2019; 114(3):14. doi:10.1007/s00395-019-0723-4.
  • Jiang Q, Liu S, Jiang Q, et al. Comparison of two radiofrequency ablation devices for atrial fibrillation concomitant with a rheumatic valve procedure. Chin Med J (Engl). 2019; 132(12):1414–1419. doi:10.1097/CM9.0000000000000276.
  • Deng L, Zhang GW, Liu ZH, et al. Totally thoracoscopic surgery for atrial myxomas resection and atrial septal defect repair. Eur Rev Med Pharmacol Sci. 2017;21(3):569–575.
  • Day JR, Taylor KM, The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg. 2005;3(2):129–140. doi:10.1016/j.ijsu.2005.04.002.
  • Alam SR, Lewis SC, Zamvar V, et al. Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trial. Heart. 2015;101(20):1639–1645. doi:10.1136/heartjnl-2015-307745.
  • Mazine A, Vistarini N, Ghoneim A, et al. Very high repair rate using minimally invasive surgery for the treatment of degenerative mitral insufficiency. Can J Cardiol. 2015;31(6):744–751. doi:10.1016/j.cjca.2014.12.029.
  • Paparella D, Rotunno C, Guida P, et al. Minimally invasive heart valve surgery: influence on coagulation and inflammatory response. Interact Cardiovasc Thorac Surg. 2017;25(2):225–232. doi:10.1093/icvts/ivx090.
  • Larmann J, Theilmeier G, Inflammatory response to cardiac surgery: cardiopulmonary bypass versus non-cardiopulmonary bypass surgery. Best Pract Res Clin Anaesthesiol. 2004; 18(3):425–438. doi:10.1016/j.bpa.2003.12.004.
  • Nguyen BA, Fiorentino F, Reeves BC, et al. Mini bypass and proinflammatory leukocyte activation: A randomized controlled trial. Ann Thorac Surg. 2016;101(4):1454–1463. doi:10.1016/j.athoracsur.2015.09.029.
  • Liu X, Wu Y, Zhu J, et al. Totally thoracoscopic repair of atrial septal defect reduces systemic inflammatory reaction and myocardial damage in initial patients. Eur J Med Res. 2014;19(1):13. doi:10.1186/2047-783X-19-13.
  • Jiang Q, Yu T, Huang K, et al. Systemic redistribution of the intramyocardially injected mesenchymal stem cells by repeated remote ischaemic post-conditioning. J Cell Mol Med. 2018;22(1):417–428. doi:10.1111/jcmm.13331.
  • Jiang Q, Yu T, Huang K, et al. Remote ischemic postconditioning ameliorates the mesenchymal stem cells engraftment in reperfused myocardium. Plos one. 2016; 11(1):e0146074. doi:10.1371/journal.pone.0146074.
  • Jabagi H, Mielniczuk LM, Liu PP, et al. Biomarkers in the diagnosis, management, and prognostication of perioperative right failure in cardiac surgery-are we there yet? JCM. 2019;8(4):559. doi:10.3390/jcm8040559.
  • Yousuf O, Mohanty BD, Martin SS, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62(5):397–408. doi:10.1016/j.jacc.2013.05.016.
  • Dörr O, Walther C, Liebetrau C, et al. Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip). Clin Cardiol. 2018;41(4):481–487. doi:10.1002/clc.22900.
  • Ridker PM, MacFadyen JG, Everett BM, et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2018;391(10118):319–328. doi:10.1016/S0140-6736(17)32814-3.
  • Silberman S, Abu-Yunis U, Tauber R, et al. Neutrophil-lymphocyte ratio: Prognostic impact in heart surgery. Early outcomes and late survival. Ann Thorac Surg. 2018;105(2):581–586. doi:10.1016/j.athoracsur.2017.07.033.
  • Tahto E, Jadric R, Pojskic L, et al. Neutrophil-to-lymphocyte ratio and its relation with markers of inflammation and myocardial necrosis in patients with acute coronary syndrome. Med Arch. 2017;71(5):312–315. doi:10.5455/medarh.2017.71.312-315.
  • Sigurdardottir FD, Lyngbakken MN, Holmen OL, et al. Relative prognostic value of cardiac troponin I and C-reactive protein in the general population (from the Nord-Trøndelag health [HUNT] study). Am J Cardiol. 2018;121(8):949–955. doi:10.1016/j.amjcard.2018.01.004.
  • Lebon JS, Couture P, Fortier A, et al. Myocardial protection in mitral valve surgery: Comparison between minimally invasive approach and standard sternotomy. J Cardiothorac Vasc Anesth. 2018;32(2):656–663. doi:10.1053/j.jvca.2017.08.040.
  • Jung C, Bueter S, Wernly B, et al. Lactate clearance predicts good neurological outcomes in cardiac arrest patients treated with extracorporeal cardiopulmonary resuscitation. JCM. 2019;8(3):374. doi:10.3390/jcm8030374.
  • Miceli A, Murzi M, Canarutto D, et al. Minimally invasive mitral valve repair through right minithoracotomy in the setting of degenerative mitral regurgitation: early outcomes and long-term follow-up. Ann Cardiothorac Surg. 2015;4(5):422–427. doi:10.3978/j.issn.2225-319X.2015.04.10.
  • Jiang Q, Song P, Wang E, et al. Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells. J Mol Cell Cardiol. 2013;56:1–7. doi:10.1016/j.yjmcc.2012.12.016.
  • Jiang Q, Yang Y, Sun H, et al. Stable hemodynamics within “no-touch” saphenous vein graft. Ann Thorac Cardiovasc Surg. 2019. doi:10.5761/atcs.oa.19-00156. [Epub ahead of print].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.